Bio-Works Technologies Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Feb 24 | Buy€3,056 | Jonathan Royce | Individual | 6,717 | €0.47 | |
19 Feb 24 | Buy€45,425 | Peter von Ehrenheim | Individual | 100,000 | €0.46 | |
30 Nov 23 | Buy€15,295 | Peter von Ehrenheim | Individual | 28,140 | €0.54 | |
29 Nov 23 | Buy€3,241 | Jonathan Royce | Individual | 6,609 | €0.49 | |
29 Nov 23 | Buy€24,126 | Peter von Ehrenheim | Individual | 50,000 | €0.48 | |
11 Oct 23 | Buy€34,098 | Peter von Ehrenheim | Individual | 52,648 | €0.65 | |
10 Oct 23 | Buy€78,664 | Peter von Ehrenheim | Individual | 121,000 | €0.65 | |
18 Aug 23 | Buy€5,109 | Jonathan Royce | Individual | 6,038 | €0.85 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 5,334,206 | 13.7% |
Private Companies | 9,225,061 | 23.7% |
Individual Insiders | 9,333,719 | 23.9% |
General Public | 15,086,804 | 38.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,326,021 | €1.6m | 0% | no data | |||
6,025,724 | €1.3m | 0% | no data | |||
1,562,463 | €337.2k | 0% | 0.03% | |||
1,251,069 | €270.0k | 0% | 0.01% | |||
1,247,184 | €269.2k | 0% | no data | |||
1,191,471 | €257.1k | 9.16% | no data | |||
1,184,323 | €255.6k | 0% | no data | |||
854,198 | €184.4k | 0% | 0.04% | |||
747,619 | €161.4k | 0% | 0.02% | |||
730,000 | €157.6k | 0% | no data | |||
714,717 | €154.3k | 0% | no data | |||
688,857 | €148.7k | 0% | no data | |||
230,000 | €49.6k | 0% | no data | |||
139,340 | €30.1k | 5.06% | no data |